Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$15.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 5 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 28 business days late.
The 13 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Mar 3 | ATHA | Athira Pharma, Inc. | MEXER◆ | 5,856 | — | — | — | Open the original filing on SEC.gov |
| Mar 3 | ATHA | Athira Pharma, Inc. | MEXER | 5,856 | — | — | +28.3% | Open the original filing on SEC.gov |
| Jan 2 | ATHA | Athira Pharma, Inc. | SSELL | 876 | $6.88 | $6K | -4.1% | Open the original filing on SEC.gov |
| Dec 31, 2025 | ATHA | Athira Pharma, Inc. | MEXER◆ | 3,667 | — | — | — | Open the original filing on SEC.gov |
| Dec 31, 2025 | ATHA | Athira Pharma, Inc. | MEXER | 3,667 | — | — | +20.5% | Open the original filing on SEC.gov |
| Dec 24, 2025 | ATHA | Athira Pharma, Inc. | AGRANT◆ | 35,138 | — | — | — | Open the original filing on SEC.gov |
| Nov 18, 2025 | ATHA | Athira Pharma, Inc. | AGRANT | 1,000 | $2.31 | $2.3K | +5.9% | Open the original filing on SEC.gov |
| Jul 1, 2025 | ATHA | Athira Pharma, Inc. | SSELL | 8,526 | $0.2935 | $2.5K | -4.8% | Open the original filing on SEC.gov |
| Jun 30, 2025 | ATHA | Athira Pharma, Inc. | MEXER◆ | 36,666 | — | — | — | Open the original filing on SEC.gov |
| Jun 30, 2025 | ATHA | Athira Pharma, Inc. | MEXER | 36,666 | — | — | +26.1% | Open the original filing on SEC.gov |
| May 19, 2025 | ATHA | Athira Pharma, Inc. | AGRANT | 10,000 | $0.2312 | $2.3K | +7.6% | Open the original filing on SEC.gov |